Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

19199400883_6db786ce0d_b

Price hiking: US pharma’s elephant in the room

October 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Martin Shkreli, Mylan, Sanofi, Turing Pharmaceuticals, price hikes

Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending debate on the power of drug companies to charge …
Feature
november_2016_front_page

The November Issue of Pharmafocus is now live!

October 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, features, latest news, news

The latest issue of Pharmafocus is now live and ready to be read! We’ve taken the opportunity to cover some of …
News
nordicnanovector_final_logo

Nordic Nanovector to collaborate with Heidelberg Pharma to develop leukaemia treatment

October 26, 2016 Research and Development Nordic Nanovector, WILEX, heidelberg pharma, leukaemia

Nordic Nanovector has announced that they have formed a partnership with WILEX subsidiary, Heidelberg Pharma. Heidelberg Pharma specialises in the …
News
shutterstock_57369385

NHS suppliers investigated over 1000% price hikes

October 26, 2016 Research and Development, Sales and Marketing NHS, price hikes

The Competition and Marketing Authority has launched an investigation into a number of drug companies following claims that 32 drugs …
News
runners-888021_960_720

Backlash over testosterone replacement drugs builds with FDA warnings

October 26, 2016 Research and Development FDA, FDA Warning, low t, prescription testosterone

The backlash against the over-prescription of ‘testosterone boosters’ continues in the US, with the FDA taking action to add clear …
News
f_44933

New UK research illuminates new developments for anticancer treatment

October 26, 2016 Research and Development anticancer

New research from the University of Huddersfield has shed light on a new lab technique which could aid in the …
News
stocks1

Colombian pharma market to break $7 billion by 2020

October 24, 2016 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Colombia, market report

According to new findings from GlobalData, the Colombian pharmaceutical market is due to grow from $5 billion in 2015 to …
News

Phase III depression trial success for Alkermes

October 24, 2016 Research and Development, Sales and Marketing ALKS 5461, Alkermes, major depressive disorder

Biopharma company Alkermes has announced the success of its ALKS 5461 treatment in a Phase III study for the treatment …
News
lilly_scientists

Eli Lilly gains accelerated approval from FDA for soft tissue sarcoma drug

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, US, soft tissue sarcoma

Eli Lilly received the positive news that their drug, Lartruvo, has been granted accelerated approval for use in conjunction with …
News
sunset-flag-america-fields

The Pharmafocus guide to the US presidential election 2016

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing US election, feature

The US presidential election is mere weeks away, and the pharmaceutical industry and drug pricing have occupied quite a large …
Feature
novartis_window

Novartis in collaboration deal worth potential $1.2 billion with Cerulean

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerulean, NDC, Novartis

Novartis has signed an agreement with Cerulean Pharma, worth a potential $1.2 billion depending on milestones met, to co-develop nanoparticle-drug …
News
celgene_1_02

Celgene’s Otezla approved by NICE for chronic plaque psoriasis

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, NICE, apremilast, otezla

NICE has given its approval to another indication for Celgene’s Otezla (apremilast), meaning NHS patients now have access to the …
News

MSD’s antiviral drug hits endpoint targets in Phase III trials

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …
News
f_44819

Oxford Genetics boosts cell/gene therapy R&D with new facility

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford Genetics, expansion

Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its infrastructure and staff to keep …
News
vaccine3a-062568e

Sun Pharma partners with ICGEB to develop dengue vaccine

October 19, 2016 Research and Development Vaccine, dengue, icgeb, sun pharmaceutical

Indian drug firm Sun Pharma is set to join forces with the International Centre for Generic Engineering and Biotechnology (ICGEB) …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026